Caplin Point Laboratories Quarterly Results for Trading Insights
CAPLIPOINT • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹160 Cr
QSept 2025
Caplin Point Laboratories Quarterly Results Key Highlights
- Revenue of ₹564 Cr in Sept 2025 (+6.8% vs Mar 2025, +11.9% vs Sept 2024)
- Net Profit of ₹160 Cr in Sept 2025 (+10.3% vs Mar 2025, +22.1% vs Sept 2024)
- EBITDA of ₹220 Cr in Sept 2025 (+13.4% vs Mar 2025)
- Operating Margin of 35.0% in Sept 2025 (+2.0pp vs Mar 2025)
- Earnings Per Share of ₹20.32 in Sept 2025 (+8.4% vs Mar 2025)
Caplin Point Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 564 | 528 | 533 | 504 | 471 | 6.8% | 11.9% |
| Net Profit (₹ Cr) | 160 | 145 | 151 | 131 | 121 | - | - |
| EBITDA (₹ Cr) | 220 | 194 | 201 | 185 | 163 | - | - |
| EPS (₹) | 20.32 | 18.75 | 20.10 | 17.22 | 16.01 | - | - |
| Operating Margin (%) | 35.0% | 33.0% | 35.0% | 34.0% | 32.0% | - | - |
Caplin Point Laboratories Share Price Trend Around Quarterly Results
Visualize Caplin Point Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Caplin Point Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Caplin Point Laboratories
Additional stock information and data for CAPLIPOINT
Revenue Trend (₹ Cr)
Sept 2024
504
Jun 2025
533
Mar 2025
528
Sept 2025
564
Net Profit Trend (₹ Cr)
Sept 2024
131
Jun 2025
151
Mar 2025
145
Sept 2025
160
Operating Margin Trend (%)
Sept 2024
34.0%
Jun 2025
35.0%
Mar 2025
33.0%
Sept 2025
35.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Caplin Point Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹391,547.47 Cr | 1704.4 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.1 |
|
Divis Laboratories
Sept 2025 |
₹160,887.23 Cr | 6054.5 | 2,860 | 689 | +7.1% | - | 24.1% | 233.1 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,071.99 Cr | 4023.5 | 3,219 | 591 | +11.3% | - | 18.4% | 229.4 |
|
Cipla
Sept 2025 |
₹110,697.00 Cr | 1326.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹103,126.93 Cr | 1240.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores